Organigram Holdings Inc.
OGI • NASDAQ
Organigram Holdings Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO James H. Yamanaka, with a market cap of $196.3M.
Market Cap$196.3M
Employees987.0
CEOJames H. Yamanaka
CountryCanada
Healthcare
Drug Manufacturers - Specialty & Generic
Next EarningsMay 11, 2026 · In 4 weeksQ2 2026
Financials
Organigram Holdings Inc. FAQ
Common questions about Organigram Holdings Inc.
Organigram Holdings Inc. is scheduled to report earnings for Q2 2026 on May 11, 2026. Analysts estimate revenue of $52.1M.
Organigram Holdings Inc. has approximately 987 employees.